Skip to main content
Back to feed
HealthReportedLow
1.9

ELPEN advances Keratea 2 production unit, targets US market entry

Greek pharmaceutical firm ELPEN is progressing with its new 'Keratea 2' production unit and the Athens LifeTech Park, positioning for US market entry. The investment signals capacity expansion and regulatory preparation, though timeline and scale remain unspecified.

Capital.gr3 days agoGR, USCredibility 31%View source

Score Breakdown

Mosaic Score1.9
Model confidence0.3
Significance0.1
Source credibility0.3

Intelligence Tags

#pharmaceuticals#manufacturing#investment#us-market#lifetech

Locations

KerateaAthens

Entities

country
Source

Related signals

8 found